SIM
AMAG

Spark Investment Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Spark Investment Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-23,700
Closed -$146K – 356
2020
Q1 		$146K Sell
23,700
-20,700
-47% -$182K 0.08% 255
2019
Q4 		$540K Sell
44,400
-47,800
-52% -$522K 0.06% 336
2019
Q3 		$1.06M Sell
92,200
-181,300
-66% -$1.91M 0.14% 184
2019
Q2 		$2.73M Sell
273,500
-97,600
-26% -$1.05M 0.19% 165
2019
Q1 		$4.78M Buy
371,100
+251,800
+211% +$3.75M 0.22% 127
2018
Q4 		$1.81M Buy
119,300
+33,200
+39% +$633K 0.13% 215
2018
Q3 		$1.72M Hold
86,100
– – 0.1% 285
2018
Q2 		$1.68M Sell
86,100
-30,700
-26% -$679K 0.1% 271
2018
Q1 		$2.35M Hold
116,800
– – 0.15% 201
2017
Q4 		$1.55M Buy
+116,800
New +$1.76M 0.08% 311
2013
Q3 		– Sell
-16,000
Closed -$356K – 611
2013
Q2 		$356K Buy
+16,000
New +$353K 0.1% 257

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Spark Investment Management's AMAG Position: Q2 2020 in Review

Spark Investment Management sold out of AMAG Pharmaceuticals (AMAG) in Q2 2020, closing a stake of 23,700 shares — an estimated $146K sold.

Spark Investment Management first reported a position in AMAG in Q2 2013 and held it in 11 quarters. The position peaked at $4.78M in Q1 2019. 119 funds tracked by Wall St. Rank hold AMAG as of Q2 2020.

  • Spark Investment Management reported no remaining AMAG Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 23,700 AMAG Pharmaceuticals shares in Q2 2020, an estimated $146K.
  • Spark Investment Management first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • Spark Investment Management's AMAG Pharmaceuticals position peaked at $4.78M in Q1 2019.
  • 119 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.